PEPTIDE CORPUS

Why NAD+ Levels Decline with Age and How to Replenish Them

As we age, our bodies undergo countless microscopic changes that gradually erode the vitality we once took for granted. Among the most significant of these changes is the steady decline of a critical molecule called NAD+ (nicotinamide adenine dinucleotide). This coenzyme, found in every cell of your body, is essential for energy production, DNA repair, and maintaining the cellular functions that keep you feeling young and vibrant.

Last updated

The Cellular Energy Crisis
A woman in orange gym clothing raising one arm in a bicep flex and laughing, holding a shaker bottle of white liquid in her other hand.
Better energy, sharper mental clarity and improved physical performance: what optimally functioning mitochondria are supposed to feel like.

The Age-Dependent Decline of NAD+

Research has consistently shown that NAD+ levels decrease naturally as we grow older. By middle age, NAD+ concentrations in tissues critical to energy metabolism—such as muscle, liver, and brain—can decline significantly. This decline is now recognized as a fundamental driver of age-related metabolic dysfunction and reduced cellular resilience.

Scientists have identified a key culprit in this age-related NAD+ decline: an enzyme called CD38. CD38 expression and activity rise sharply with advancing age across diverse tissues, and this increase is tightly coupled to the progressive fall in NAD+ levels. In mouse models where CD38 was genetically removed, NAD+ concentrations were preserved into advanced age, and mitochondria retained respiratory capacity similar to that seen in young mice. This research positions CD38 as a gatekeeper of metabolic resilience in aging organisms.

It's important to note that NAD+ levels in skeletal muscle typically decline by up to 30% with age. However, recent research has produced nuanced findings. A study from the University of Copenhagen found that reducing skeletal muscle NAD+ levels in mice by 85% did not accelerate aging or impair whole-body metabolism. This suggests that while NAD+ decline occurs with age, it may not be the sole driver of muscle aging and frailty. The relationship between NAD+ levels and aging is complex, and more research is needed to fully understand its role.

Mitochondrial Health: The Key to Lasting Energy

Healthy mitochondria are essential for sustaining youthful energy levels and overall vitality. Mitochondria—often called the powerhouses of the cell—convert nutrients into ATP, the energy currency that fuels everything from muscle contraction to brain function. When mitochondria function optimally, you experience better energy, sharper mental clarity, and improved physical performance.

NAD+ plays a central role in this process. It acts as a critical cofactor in the electron transport chain, the mitochondrial pathway responsible for ATP production. The functional link between NAD+ and mitochondria is so significant that NAD+ decline triggers mitochondrial dysfunction through several mechanisms: increased reactive oxygen species (ROS), impaired mitochondrial turnover (mitophagy), and disruption of the mitochondrial unfolded protein response (UPRmt), which normally prevents damage by removing aggregated or unfolded proteins.

How NAD+ Precursors Support Healthy Aging

NAD+ molecules are too large to be absorbed directly from supplements, so the primary strategy for replenishing NAD+ levels involves taking precursors that the body converts into NAD+. The most studied precursors include nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid (NA), and nicotinamide (NAM).

Research suggests these precursors offer promise for maintaining cellular health. By raising NAD+ levels, supplementation may support mitochondrial functionality, enhance fatty acid oxidation, and support the activity of sirtuins—proteins that regulate longevity pathways and stress resistance. Clinical trials have been conducted on NAD+ precursors for aging and neurodegenerative diseases, with researchers now seeking to determine optimal dose, administration routes, and long-term safety.

While NAD+ supplementation is not a miracle cure, the evidence supports its potential role in preserving the cellular energy systems that decline with age—allowing you to maintain a more youthful level of vitality for longer. However, recent findings suggest the relationship between NAD+ and aging may be more nuanced than previously thought, and further large-scale studies are needed.

Glossary

ATP (Adenosine Triphosphate)
The primary energy currency of cells. ATP is produced by mitochondria and powers most cellular processes.
CD38
An enzyme that breaks down NAD+. CD38 activity increases with age and is considered a key driver of age-related NAD+ decline.
Cofactor
A non-protein chemical compound that is required for a protein's biological activity. NAD+ serves as a cofactor for many enzymes.
Mitochondria
Organelles within cells that are responsible for producing energy (ATP) through cellular respiration.
Mitophagy
The selective degradation of damaged mitochondria by cells. This process helps maintain mitochondrial quality.
NAD+ (Nicotinamide Adenine Dinucleotide)
A critical coenzyme found in every cell, essential for energy production, DNA repair, and cellular function. NAD+ levels decline with age.
NAD+ Precursors
Compounds that the body can convert into NAD+, such as NMN, NR, nicotinic acid, and nicotinamide.
NMN (Nicotinamide Mononucleotide)
A precursor to NAD+ that is converted by the body into NAD+.
NR (Nicotinamide Riboside)
Another NAD+ precursor, which is converted to NAD+ through a different pathway than NMN.
Sirtuins
A family of proteins that regulate cellular health and longevity pathways. Sirtuins require NAD+ to function.

Sources and evidence

Sources and evidence

5 sources
Systemic NAD+ decline triggers mitochondrial dysfunction and epigenetic changes. NatureReview

How this source supports the article

What NAD+ decline does downstream: mitochondrial dysfunction through increased reactive oxygen species, impaired mitophagy, and disruption of the mitochondrial unfolded protein response.

Limitations

It describes mechanism rather than testing an intervention, and the work behind it is largely in animal and cell models.

CD38 as a driver of ageing. Nature Reviews Endocrinology, 2026Review

How this source supports the article

That CD38 expression and activity rise sharply with age across diverse tissues, that the rise is coupled to the fall in NAD+, and that CD38-knockout mice preserve NAD+ and mitochondrial respiratory capacity into advanced age.

Limitations

The knockout evidence is in mice. No human trial has tested whether lowering CD38 activity changes an ageing outcome.

NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. Cell Metabolism, University of Copenhagen, 2025Animal in vivo

How this source supports the article

The result that reducing skeletal muscle NAD+ levels in mice by 85% did not accelerate aging or impair whole-body metabolism.

Limitations

Mice, and skeletal muscle specifically. An engineered tissue-specific depletion is not the same exposure as the systemic decline that occurs with age.

Review of NAD+ metabolism and mitochondrial modulation in aging. Nature, 2025Review

How this source supports the article

NAD+'s role as a cofactor in the electron transport chain, and the case that raising NAD+ may support mitochondrial functionality, fatty acid oxidation and sirtuin activity.

Limitations

A review, so it summarises other work rather than producing its own, and most of the primary evidence it draws on is preclinical.

Clinical strategies for targeting NAD+. Nature Aging, 2025Review

How this source supports the article

The precursor list — NMN, NR, nicotinic acid and nicotinamide — and that clinical trials have run in aging and neurodegenerative disease with optimal dose, administration route and long-term safety still open.

Limitations

It sets out the clinical strategy rather than reporting a completed trial, and the trials it surveys are mostly small and short.

Peptide Corpus is a record and a calculator. It is not a clinician and it does not recommend a compound or a dose. Where the evidence is thin we name the gap on the record itself.